These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32743697)

  • 1. Hepatitis D virus seroprevalence in Egyptian HBsAg-positive children: a single-center study.
    Fouad HM; Ahmed A; Reyad EM; ElSadek SM; Khattab RA; El Damasy DA
    Arch Virol; 2020 Oct; 165(10):2361-2365. PubMed ID: 32743697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reduction of HBV and HDV infection in two indigenousmpeoples of Peruvian Amazon after the vaccination against hepatitis B].
    Cabezas C; Trujillo O; Balbuena J; Terrazas M; Manrique-de Lara C; Marín L; Ramírez-Soto MC
    Salud Publica Mex; 2020; 62(3):237-245. PubMed ID: 32520481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
    Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
    J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B.
    Cabezas C; Trujillo O; Balbuena J; Peceros FM; Terrazas M; Suárez M; Marin L; Apac J; Ramírez-Soto MC
    PLoS One; 2020; 15(8):e0236993. PubMed ID: 32760100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
    Makhlouf NA; Morsy KH; Mahmoud AA
    J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.
    Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M
    J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and molecular characterization of hepatitis D virus in Saudi Arabia: A single-center study.
    Jamjoom GA; El-Daly MM; Azhar EI; Fallatah HI; Akbar HO; Babatin M; Alghamdi AS; Dgdgi MI; Hamid MA; Qari YA; El-Kafrawy SA
    Saudi J Gastroenterol; 2017; 23(3):176-182. PubMed ID: 28611341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy.
    De Paschale M; Manco MT; Belvisi L; Magnani C; Re T; Viganò P; Biagiotti S; Capelli F; Mazzone A; Baldacci MP; Ferrara A; Neri AL; Guastoni CM; Bonazzina RA; Brando B; Clerici P
    Infection; 2012 Oct; 40(5):485-91. PubMed ID: 22367777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon.
    Viana S; Paraná R; Moreira RC; Compri AP; Macedo V
    Am J Trop Med Hyg; 2005 Oct; 73(4):808-14. PubMed ID: 16222030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre.
    Das K; Ali H; Mahmood T; Munir SM; Ahmed T; Farooq MU
    J Ayub Med Coll Abbottabad; 2008; 20(2):39-42. PubMed ID: 19385455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on seroprevalence of hepatitis delta in a regional hospital in western Turkey.
    Kose S; Ece G; Gozaydin A; Turken M
    J Infect Dev Ctries; 2012 Nov; 6(11):782-5. PubMed ID: 23277503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, Egypt.
    Elzefzafy W; Soliman R; Saleh L; Mahmoud S; Makhlouf NA; Shiha G; Zaky S
    J Viral Hepat; 2022 Jan; 29(1):87-90. PubMed ID: 34582608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity].
    Iashina TL; Favorov MO; Shakhgil'dian IV; Firsova SN; Eraliev AE; Zhukova LD; Reznichenko RG
    Vopr Virusol; 1992; 37(4):194-6. PubMed ID: 1471341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hepatitis B and delta coinfection in Israel.
    Shirazi R; Ram D; Rakovsky A; Bucris E; Gozlan Y; Lustig Y; Shaked-Mishan P; Picard O; Shemer-Avni Y; Ben-Zvi H; Halutz O; Lurie Y; Veizman E; Carlebach M; Braun M; Naftaly MC; Shlomai A; Safadi R; Mendelson E; Sklan EH; Ben-Ari Z; Mor O
    BMC Infect Dis; 2018 Feb; 18(1):97. PubMed ID: 29486716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with hepatitis B and D virus infections among migrant sex workers in Chiangmai, Thailand: A cross-sectional study in 2019.
    Hongjaisee S; Khamduang W; Sripan P; Choyrum S; Thepbundit V; Ngo-Giang-Huong N; Tangmunkongvorakul A
    Int J Infect Dis; 2020 Nov; 100():247-254. PubMed ID: 32898671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.